PRAMETRAK Trademark
Trademark Overview
On Tuesday, May 31, 2022, a trademark application was filed for PRAMETRAK with the United States Patent and Trademark Office. The USPTO has given the PRAMETRAK trademark a serial number of 97435350. The federal status of this trademark filing is PUBLISHED FOR OPPOSITION as of Tuesday, November 12, 2024. This trademark is owned by Immunocore Limited. The PRAMETRAK trademark is filed in the Pharmaceutical Products category with the following description:
Pharmaceutical preparations, biological preparations and bispecific reagents for the treatment of tumorous diseases; pharmaceutical preparations, biological preparations and bispecific reagents for the treatment of cancer; pharmaceutical preparations, biological preparations and bispecific reagents for the treatment of melanoma, lung cancer, ovarian cancer, uterine cancer, breast cancer, neurothelial cancer, endometrial cancer, oesophageal cancer, sarcoma, haematological cancers, acute myeloid leukemia, chronic myeloid leukemia, Hodgkin's lymphoma, and head and neck cancers
General Information
Serial Number | 97435350 |
Word Mark | PRAMETRAK |
Filing Date | Tuesday, May 31, 2022 |
Status | 686 - PUBLISHED FOR OPPOSITION |
Status Date | Tuesday, November 12, 2024 |
Registration Number | 0000000 |
Registration Date | NOT AVAILABLE |
Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
Published for Opposition Date | Tuesday, November 12, 2024 |
Trademark Statements
Goods and Services | Pharmaceutical preparations, biological preparations and bispecific reagents for the treatment of tumorous diseases; pharmaceutical preparations, biological preparations and bispecific reagents for the treatment of cancer; pharmaceutical preparations, biological preparations and bispecific reagents for the treatment of melanoma, lung cancer, ovarian cancer, uterine cancer, breast cancer, neurothelial cancer, endometrial cancer, oesophageal cancer, sarcoma, haematological cancers, acute myeloid leukemia, chronic myeloid leukemia, Hodgkin's lymphoma, and head and neck cancers |
Classification Information
International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
Class Status Code | 6 - Active |
Class Status Date | Tuesday, June 7, 2022 |
Primary Code | 005 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
Trademark Owner History
Party Name | Immunocore Limited |
Party Type | 20 - Owner at Publication |
Legal Entity Type | 99 - Other |
Address | Abingdon, Oxfordshire OX144RY GB |
Party Name | Immunocore Limited |
Party Type | 10 - Original Applicant |
Legal Entity Type | 99 - Other |
Address | Abingdon, Oxfordshire OX144RY GB |
Trademark Events
Event Date | Event Description |
Friday, June 3, 2022 | NEW APPLICATION ENTERED |
Tuesday, June 7, 2022 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
Wednesday, December 28, 2022 | ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY |
Thursday, March 16, 2023 | ASSIGNED TO EXAMINER |
Thursday, March 23, 2023 | NON-FINAL ACTION WRITTEN |
Thursday, March 23, 2023 | NON-FINAL ACTION E-MAILED |
Thursday, March 23, 2023 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
Friday, June 9, 2023 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
Tuesday, November 14, 2023 | ASSIGNED TO LIE |
Tuesday, November 14, 2023 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
Tuesday, November 14, 2023 | TEAS/EMAIL CORRESPONDENCE ENTERED |
Thursday, November 16, 2023 | APPROVED FOR PUB - PRINCIPAL REGISTER |
Wednesday, November 29, 2023 | ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED |
Wednesday, October 23, 2024 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
Tuesday, November 12, 2024 | PUBLISHED FOR OPPOSITION |
Tuesday, November 12, 2024 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
Wednesday, November 20, 2024 | ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY |